News Chordate Medical Holding AB

Equities

CMH

SE0009495559

Delayed Nasdaq Stockholm Other stock markets 05:38:29 2024-05-16 am EDT			5-day change	1st Jan Change
0.0546 ^SEK	+3.80%		-14.69%	-65.96%

May. 07	Chordate Medical Receives Patent Approval in the US	CI
Mar. 22	Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Communiqué from the Annual General Meeting of Chordate Medical Holding AB (publ)	May. 15	AQ
Chordate Presents Ozilia at Pharma Partnering EU Summit 2024	May. 15	AQ
BioStock: Chordate Medical receives patent approval in the US	May. 07	AQ
Chordate Medical Receives Patent Approval in the US	May. 07	CI
Chordate will be granted a fourth patent in the USA	May. 03	AQ
Chordate's board member to BioStock: "Women's health is a concern for society at large"	Apr. 30	AQ
Chordate presents Ozilia at LSX World Congress on April 29-30	Apr. 25	AQ
Chordate presents Ozilia to national specialist associations from Germany, Switzerland, & Austria	Apr. 22	AQ
Chordate presents at the Feminvest investor conference in Oslo	Apr. 18	AQ
Chordate Medical Holding AB (publ) Appoints Lago Kapital as Liquidity Provider	Apr. 18	AQ
Notice to the Annual General Meeting in Chordate Medical Holding AB (publ)	Apr. 15	AQ
Chordate Medical Holding AB publishes annual report for 2023	Apr. 12	AQ
BioStock: Chordate comments on Q4 and case report	Apr. 03	AQ
Chordate Medical's CEO Anders Weilandt interviewed about year-end report by Finwire	Mar. 26	AQ
Year-End Report Chordate Medical Holding AB (publ) January - December 2023	Mar. 22	AQ
Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 22	CI
Chordate Medical Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 22	CI
Chordate Medical presents Year-end report for 2023 on Finwire TV	Mar. 21	AQ
BioStock: Chordate's CEO presented at Swiss Nordic Bio	Mar. 12	AQ
New case report with Ozilia published: "Effective for both pain relief and reduced frequency of migraine attacks"	Mar. 11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Chordate Medical Holding AB

Equities

CMH

SE0009495559

Summary

Filters